Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Macrovascular disease may contribute to increased risk of accelerated cognitive decline in patients with type 2 diabetes. We aimed to determine associations of measures of macrovascular disease with cognitive change in a cognitively healthy older population with type 2 diabetes. RESEARCH DESIGN AND METHODS: Eight hundred thirty-one men and women (aged 60–75 years) attended two waves of the prospective Edinburgh Type 2 Diabetes Study (ET2DS). At baseline, clinical and subclinical macrovascular disease was measured, including cardiovascular event history, carotid intima-media thickness (cIMT), ankle brachial index (ABI), and serum N-terminal probrain natriuretic peptide (NT-proBNP). Seven neuropsychological tests were administered at baseline and after 4 years; scores were combined to a standardized general ability factor (g). Adjustment of follow-up g for baseline g assessed 4-year cognitive change. Adjustment for vocabulary (estimated premorbid ability) was used to estimate lifetime cognitive change. RESULTS: Measures of cognitive decline were significantly associated with stroke, NT-proBNP, ABI, and cIMT, but not with nonstroke vascular events. The association of stroke with increased estimated lifetime cognitive decline (standardized β, −0.12) and of subclinical markers with actual 4-year decline (standardized β, −0.12, 0.12, and −0.15 for NT-proBNP, ABI, and cIMT, respectively) reached the Bonferroni-adjusted level of statistical significance (P < 0.006). Results altered only slightly on adjustment for vascular risk factors. CONCLUSIONS: Stroke and subclinical markers of cardiac stress and generalized atherosclerosis are associated with cognitive decline in older patients with type 2 diabetes. Further investigation into the potential use of subclinical vascular disease markers in predicting cognitive decline is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“According to Feinkohl I. et al., cIMT is also a significant predictor of cognitive decline in patients with T2DM [71].”
From Neuroprotective effect of SGLT2 inhibitors. (2021) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
"General Intelligence," Objectively Determined and Measured
Spearman, C. (1904) · The American Journal of Psychology · doi:10.2307/1412107 · Cited by 6,207
Stern, Y. (2009) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2009.03.004 · Cited by 2,943
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187 · cited 1×
“Understanding the role of macrovascular disease in age-related cognitive impairment is particularly important in diabetes, given the higher prevalence of atherosclerotic large vessel disease as well as the accelerated cognitive decline and increased risk of cognitive impairment (5,6) associated with this condition, an…”
BackgroundWhen does age-related cognitive decline begin?
Salthouse, T. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.09.023 · Cited by 1,848 · cited 2×
“Cognitive abilities are essential for independent living in later life, and some domains of cognitive functioning decline in mean level from relatively early adulthood (1).”
BackgroundVitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Authors/Task Force Members, Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,647
Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies
Cukierman, T., Gerstein, H. C., & Williamson, J. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0023-4 · Cited by 1,049
Cardiovascular risk factors and cognitive decline in middle-aged adults
Knopman, D., Boland, L. L., Mosley, T., Howard, G., Liao, D., Szklo, M., McGovern, P., & Folsom, A. R. (2001) · Neurology · doi:10.1212/wnl.56.1.42 · Cited by 883
Lend, G. C., & Fowkes, F. G. R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90150-l · Cited by 531
Haan, M. N. (1999) · JAMA · doi:10.1001/jama.282.1.40 · Cited by 457
Trends in Death Rates Among U.S. Adults With and Without Diabetes Between 1997 and 2006
Gregg, E. W., Cheng, Y. J., Saydah, S., Cowie, C., Garfield, S., Geiss, L., & Barker, L. (2012) · Diabetes Care · doi:10.2337/dc11-1162 · Cited by 303
The reliability and validity of the mini-mental state in a British community survey
O'Connor, D. W., Pollitt, P. A., Hyde, J. B., Fellows, J. L., Miller, N. D., Brook, C. P. B., & Reiss, B. B. (1989) · Journal of Psychiatric Research · doi:10.1016/0022-3956(89)90021-6 · Cited by 301
Long-Term Effects of Childhood Obesity on Morbidity and Mortality
Maffeis, C., & Tatò, L. (2001) · Hormone Research in Paediatrics · doi:10.1159/000063462 · Cited by 266
Use and Utility of Ankle Brachial Index in Patients with Diabetes
Potier, L., Abi Khalil, C., Mohammedi, K., & Roussel, R. (2011) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2010.09.020 · Cited by 253 · cited 2×
“Markers of subclinical atherosclerosis also are altered, with increased average carotid intima-media thickness (cIMT) (11) and reduced mean ankle brachial index (ABI) (12).”
BackgroundResultGuidelines on Diabetes, Pre-Diabetes, and Cardiovascular Diseases: Executive Summary
Rydén, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., De Boer, M.-J., Cosentino, F., Jönsson, B., Laakso, M., Malmberg, K., et al. (2007) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(07)60205-9 · Cited by 242
Brohall, G., Odén, A., & Fagerberg, B. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01725.x · Cited by 203 · cited 2×
“Markers of subclinical atherosclerosis also are altered, with increased average carotid intima-media thickness (cIMT) (11) and reduced mean ankle brachial index (ABI) (12).”
BackgroundDiagnostic Value of Ankle-Brachial Index in Peripheral Arterial Disease: A Meta-analysis
Xu, D., Zou, L., Xing, Y., Hou, L., Wei, Y., Zhang, J., Qiao, Y., Hu, D., Xu, Y., Li, J., et al. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.06.014 · Cited by 183 · cited 1×
“The associations of cognitive decline with subclinical measures of macrovascular disease, including higher levels of NTproBNP, increased thickness of the cIMT, and lower ankle brachial pressure (a further measure of systemic atherosclerotic disease as well as of lower limb peripheral arterial disease) (32), appeared s…”
ResultCognitive Decline and Markers of Inflammation and Hemostasis: The Edinburgh Artery Study
Rafnsson, S. B., Deary, I. J., Smith, F. B., Whiteman, M. C., Rumley, A., Lowe, G. D. O., & Fowkes, F. G. R. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01158.x · Cited by 170 · cited 1×
“Details of this approach have been published previously (26); essentially, by controlling for a well-validated estimate of peak cognitive ability, it was possible to assess associations of macrovascular disease variables with estimated decline from bestever level of cognitive function.”
MethodSelf-citationMarioni, R. E., Strachan, M. W. J., Reynolds, R. M., Lowe, G. D. O., Mitchell, R. J., Fowkes, F. G. R., Frier, B. M., Lee, A. J., Butcher, I., Rumley, A., et al. (2010) · Diabetes · doi:10.2337/db09-1163 · Cited by 167 · cited 2×
“Details of recruitment have been described previously (15) and representativeness of the cohort has been demonstrated by comparing demographic and clinical characteristics of responders and nonresponders (16).”
MethodSelf-citationDiabetic Retinopathy and Cognitive Decline in Older People With Type 2 Diabetes
Ding, J., Strachan, M. W. J., Reynolds, R. M., Frier, B. M., Deary, I. J., Gerald, F. F. R., Lee, A. J., McKnight, J., Halpin, P., Swa, K., et al. (2010) · Diabetes · doi:10.2337/db10-0752 · Cited by 162
Self-citationWendell, C. R., Zonderman, A. B., Metter, E. J., Najjar, S. S., & Waldstein, S. R. (2009) · Stroke · doi:10.1161/strokeaha.109.557280 · Cited by 158 · cited 1×
“Evidence for associations with cognitive decline is mixed (36,37), however, and although our finding of accelerated 4-year cognitive decline in individuals with higher cIMT is consistent with one previous study performed in a nondiabetic population (36), investigations of patients with type 2 diabetes are lacking.”
ResultStroke in patients with diabetes mellitus
Mankovsky, B., & Ziegler, D. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.490 · Cited by 142 · cited 7×
“The prevalence of stroke, of transient ischemic attack (TIA) (8), and of coronary heart disease (9) are higher in diabetic populations than in nondiabetic populations, and average natriuretic peptide levels, a marker of cardiac stress, are increased (10).”
BackgroundInfluentialMagnusson, M., Melander, O., Israelsson, B., GRUBB, A. O., Groop, L., & Jovinge, S. V. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1929 · Cited by 118 · cited 1×
“The prevalence of stroke, of transient ischemic attack (TIA) (8), and of coronary heart disease (9) are higher in diabetic populations than in nondiabetic populations, and average natriuretic peptide levels, a marker of cardiac stress, are increased (10).”
BackgroundPredictors of Cognitive Decline in Older Individuals With Diabetes
Bruce, D. G., Davis, W. A., Casey, G. P., Starkstein, S. E., Clarnette, R. M., Almeida, O. P., & Davis, T. M. E. (2008) · Diabetes Care · doi:10.2337/dc08-0562 · Cited by 115 · cited 1×
“Contrary to previous investigations in older adults with type 2 diabetes (30,31), stroke also appeared to be associated with rate of actual late-life cognitive decline over the 4-year followup, although these associations were weaker and less statistically significant, suggesting that cognitive function deteriorates f…”
ResultVascular Disease and Cognitive Function: Evidence from the Whitehall II Study
Singh‐Manoux, A., Britton, A. R., & Marmot, M. G. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51464.x · Cited by 102 · cited 1×
“Systemic atherosclerotic changes in the body may serve as a marker of vascular-related changes in the brain (2) that, in turn, lead to cognitive deficits (3,4).”
BackgroundAneurysms in Twig-Like Middle Cerebral Artery
Liu, H., Lai, D., Tu, Y., & Wang, Y.-H. (2005) · Cerebrovascular Diseases · doi:10.1159/000086119 · Cited by 95
Pendlebury, S. T., & Rothwell, P. M. (2009) · Cerebrovascular Diseases · doi:10.1159/000209260 · Cited by 92 · cited 1×
“Stroke is a well-established risk factor associated with cognitive dysfunction and impairment (28), and also may contribute to accelerated cognitive decline (29), although the relationship in exclusively diabetic populations has not been extensively investigated.”
BackgroundAccelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors
Reijmer, Y. D., van den Berg, E., de Bresser, J., Kessels, R. P. C., Kappelle, L. J., Algra, A., Biessels, G. J., & on behalf of the Utrecht Diabetic Encephalopathy Study Group (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1163 · Cited by 89
[The minimental state examination--an up-to-date review].
Lancu, I., & Olmer, A. (2006) · PubMed · Cited by 83
Rafnsson, S. B., Deary, I. J., Smith, F. B., Whiteman, M. C., & Fowkes, F. G. R. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318068fce4 · Cited by 79 · cited 1×
“Systemic atherosclerotic changes in the body may serve as a marker of vascular-related changes in the brain (2) that, in turn, lead to cognitive deficits (3,4).”
BackgroundSelf-citationEstimation of premorbid intelligence in dementia
O’Carroll, R. E., & Gilleard, C. J. (1986) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.1986.tb00690.x · Cited by 71
The Edinburgh Type 2 Diabetes Study: study protocol
Price, J. F., Reynolds, R. M., Mitchell, R. J., Williamson, R. M., Fowkes, F. G. R., Deary, I. J., Lee, A. J., Frier, B. M., Hayes, P. C., & Strachan, M. W. (2008) · BMC Endocrine Disorders · doi:10.1186/1472-6823-8-18 · Cited by 68 · cited 2×
“Details of recruitment have been described previously (15) and representativeness of the cohort has been demonstrated by comparing demographic and clinical characteristics of responders and nonresponders (16).”
MethodSelf-citationKerola, T., Nieminen, T., Hartikainen, S., Sulkava, R., Vuolteenaho, O., & Kettunen, R. (2010) · Annals of Medicine · doi:10.3109/07853891003652542 · Cited by 66
Price, J. F., McDowell, S. E., Whiteman, M. C., Deary, I. J., Stewart, M. C. W., & Fowkes, F. G. R. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00702.x · Cited by 63 · cited 1×
“Contrary to previous investigations performed in predominantly nondiabetic populations (38,39), we found an association between low ABI and steeper latelife cognitive decline.”
ResultSelf-citationGunstad, J., Poppas, A., Smeal, S., Paul, R. H., Tate, D. F., Jefferson, A. L., Forman, D. E., & Cohen, R. A. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.02.062 · Cited by 59
Harron, K. L., Feltbower, R. G., McKinney, P. A., Bodansky, H. J., Campbell, F., & Parslow, R. C. (2011) · Diabetes Care · doi:10.2337/dc10-1512 · Cited by 55
An 'instantaneous' estimate of a lifetime's cognitive change
Deary, I. J. (2003) · Intelligence · doi:10.1016/j.intell.2003.06.001 · Cited by 54
Self-citationGolden, S. H. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.017 · Cited by 28 · cited 1×
“Understanding the role of macrovascular disease in age-related cognitive impairment is particularly important in diabetes, given the higher prevalence of atherosclerotic large vessel disease as well as the accelerated cognitive decline and increased risk of cognitive impairment (5,6) associated with this condition, an…”
BackgroundJohnson, W., Price, J. F., Rafnsson, S. B., Deary, I. J., & Fowkes, F. G. R. (2010) · Vascular Medicine · doi:10.1177/1358863x09356321 · Cited by 22
Self-citationGállego, J., & Martínez‐Vila, E. (2005) · Cerebrovascular Diseases · doi:10.1159/000089351 · Cited by 20
Carotid artery intima media thickness a predictor of cognitive impairment
Saleh, C. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e157 · Cited by 19 · cited 1×
“Increased cIMT has been shown to be a marker of coexistent CVD, including cerebrovascular disease (35), and may indicate systemic atherosclerosis as well as more localized disease.”
Background
Cited by
Biessels, G. J., Strachan, M. W. J., Visseren, F. L. J., Kappelle, L. J., & Whitmer, R. A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70088-3 · Cited by 551
Self-citationInflammation: the link between comorbidities, genetics, and Alzheimer’s disease
Newcombe, E. A., Camats-Perna, J., Silva, M. L., Valmas, N., Huat, T. J., & Medeiros, R. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1313-3 · Cited by 532
Cognitive function in patients with diabetes mellitus: guidance for daily care
Koekkoek, P. S., Kappelle, L. J., van den Berg, E., Rutten, G. E. H. M., & Biessels, G. J. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70249-2 · Cited by 393
Neuroprotective effect of SGLT2 inhibitors.
Pawlos, A., Broncel, M., Woźniak, E., & Gorzelak-Pabiś, P. (2021) · Molecules · doi:10.3390/molecules26237213 · Cited by 304
Diabetes mellitus and cognitive impairments
Saedi, E., Gheini, M. R., Faiz, F., & Arami, M. A. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i17.412 · Cited by 267
Metadata
- Authors
- Feinkohl, I., Keller, M., Robertson, C. M., Morling, J. R., Williamson, R. M., Nee, L. D., McLachlan, S., Sattar, N., Welsh, P., Reynolds, R. M., Russ, T. C., Deary, I. J., Strachan, M. W. J., Price, J. F., & on behalf of the Edinburgh Type 2 Diabetes Study (ET2DS) Investigators
- Affiliations
- University of Edinburgh (GB)
- Centre for Population Health Sciences, University of Edinburgh, Edinburgh, Scotland, United Kingdom
- Western General Hospital (GB)
- University of Glasgow (GB)
- The Queen's Medical Research Institute (GB)
- National Health Service (GB)
- Corresponding author
- Feinkohl, Insa
- Price, Jackie F.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-08-13
- Volume
- 36
- Issue
- 9
- Pages
- 2779-2786
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3747922
- OpenAlex
- W2169715537
- Cited by
- 69
- References
- 49
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 9 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 6 · 2016: 5 · 2015: 6 · 2014: 11 · 2013: 3
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- British Heart Foundation (FS/12/62/29889, FS/10/005/28147)
- Medical Research Council (MR/K026992/1)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- type 2 diabetes, cognitive decline, macroangiopathy, stroke, carotid intima-media thickness, ankle-brachial index, NT-proBNP, subclinical atherosclerosis, cardiovascular risk, older adults, general intelligence
- MeSH terms
- Aged, Cognition Disorders, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged, Prospective Studies, Biomarkers, Stroke, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
